![conference banner](/images/conference-banner.jpeg)
Abstract
Human herpes viruses (HHV) are leading cause of human viral diseases, second after influenza and cold viruses. They cause overt disease or can remain silent for many years waiting for reactivation. HHV are associated to several side-effects or co-conditions like Alzheimers disease, cholangiocarcinoma and pancreatic cancer, and with the time, they have become resistant to the available commercial drugs like acyclovir, whose final target is the DNApolymerase. For this reason there is an increasing interest for the search of novel compounds against herpes viruses. In this sense, Bioinformatics is determinant for a better understanding of the mechanisms of resistance, and also for the search of new biomolecular targets for the design of more potent and versatile anti-herpes agents. This review is focused on the role of Bioinformatics toward the design of compounds with anti-herpetic activity and also we propose a model based fragment descriptors for the design, search and prediction of anti-herpes compounds through the inhibition of 5 targets belonging to different herpes viruses.
Keywords: DNA-polymerase and protease inhibitors, QSAR, molecular docking, anti-herpetic activity, linear discriminant analysis, fragment, Human herpes viruses, Mucoepithelial, Varicella zoster virus, Uracil-DNA Glycosylase, B cells and epithelial cell, Transcriptional Regulatory Protein
Current Bioinformatics
Title: Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents
Volume: 6 Issue: 1
Author(s): Alejandro Speck-Planche and M. Natalia D.S. Cordeiro
Affiliation:
Keywords: DNA-polymerase and protease inhibitors, QSAR, molecular docking, anti-herpetic activity, linear discriminant analysis, fragment, Human herpes viruses, Mucoepithelial, Varicella zoster virus, Uracil-DNA Glycosylase, B cells and epithelial cell, Transcriptional Regulatory Protein
Abstract: Human herpes viruses (HHV) are leading cause of human viral diseases, second after influenza and cold viruses. They cause overt disease or can remain silent for many years waiting for reactivation. HHV are associated to several side-effects or co-conditions like Alzheimers disease, cholangiocarcinoma and pancreatic cancer, and with the time, they have become resistant to the available commercial drugs like acyclovir, whose final target is the DNApolymerase. For this reason there is an increasing interest for the search of novel compounds against herpes viruses. In this sense, Bioinformatics is determinant for a better understanding of the mechanisms of resistance, and also for the search of new biomolecular targets for the design of more potent and versatile anti-herpes agents. This review is focused on the role of Bioinformatics toward the design of compounds with anti-herpetic activity and also we propose a model based fragment descriptors for the design, search and prediction of anti-herpes compounds through the inhibition of 5 targets belonging to different herpes viruses.
Export Options
About this article
Cite this article as:
Speck-Planche Alejandro and Natalia D.S. Cordeiro M., Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents, Current Bioinformatics 2011; 6 (1) . https://dx.doi.org/10.2174/157489311795222392
DOI https://dx.doi.org/10.2174/157489311795222392 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serum miRNAs Signature Plays an Important Role in Keloid Disease
Current Molecular Medicine TWIST1 Gene: First Insights in Felis catus
Current Genomics Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry MicroRNA: Promising Roles in Cancer Therapy
Current Pharmaceutical Biotechnology Cucurbitacin IIb from Ibervillea sonorae Induces Apoptosis and Cell Cycle Arrest via STAT3 Inhibition
Anti-Cancer Agents in Medicinal Chemistry Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
Current Cancer Drug Targets Dietary Manipulation of Precursor Polyunsaturated Fatty Acids Modulates Eicosanoid and Endocannabinoid Synthesis: A Potential Tool to Control Tumor Development
Current Nutrition & Food Science Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
Current Drug Therapy Modulation of pRb/E2F Functions in the Regulation of Cell Cycle and in Cancer
Current Cancer Drug Targets Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Gene Delivery for Periodontal Tissue Engineering: Current Knowledge – Future Possibilities
Current Gene Therapy Circular RNA and Diabetes: Epigenetic Regulator with Diagnostic Role
Current Molecular Medicine Lactoferrin: A Biologically Active Molecule for Bone Regeneration
Current Medicinal Chemistry Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones
Current Medicinal Chemistry Cellular Senescence and Anti-Cancer Therapy
Current Drug Targets Recent Progress on the Role of Fibronectin in Tumor Stromal Immunity and Immunotherapy
Current Topics in Medicinal Chemistry Iron Oxide Nanoparticles: An Insight into their Biomedical Applications
Current Medicinal Chemistry From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Current Cancer Drug Targets A Revision of Polymeric Nanoparticles as a Strategy to Improve the Biological Activity of Melatonin
Current Medicinal Chemistry